Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
ALDX holding history
Aldeyra Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALDX overviewAll 13F holders of ALDXFull Q1 2025 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −544−100.0% | Sold out | Holders |
| Q1 2024 | 544 | $1.78K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 544 | $1.91K | <0.1% | −234−30.1% | Reduced | Holders |
| Q3 2023 | 778 | $5.20K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 778 | $6.53K | <0.1% | +417+115.5% | Added | Holders |
| Q1 2023 | 361 | $3.58K | <0.1% | −151−29.5% | Reduced | Holders |
| Q4 2022 | 512 | $3.56K | <0.1% | −249−32.7% | Reduced | Holders |
| Q3 2022 | 761 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 761 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 761 | $3.00K | <0.1% | −1,780−70.1% | Reduced | Holders |
| Q4 2021 | 2,541 | $10.0K | <0.1% | +2,541 | New | Holders |